Amneal Pharmaceuticals Of New York, LLC FDA Inspection Record
Amneal Pharmaceuticals Of New York, LLC is an FDA-registered facility (FEI 2434153) located in Hauppauge, NY, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 11 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Feb 3, 2020: No Action Indicated (NAI)
- Inspections on record
- 11 (7 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 4, latest Aug 17, 2013
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 3, 2020 | No Action Indicated (NAI) | No citations listed |
| Mar 18, 2019 | Voluntary Action Indicated (VAI) | Storage under appropriate conditions (21 CFR 211.142(b)) |
| Apr 11, 2017 | Voluntary Action Indicated (VAI) | Clothing appropriate for duties performed (21 CFR 211.28(a)) |
| Aug 9, 2016 | Voluntary Action Indicated (VAI) | Late submission of quarterly safety reports (21 CFR 314.80(c)(2)) Late submission of annual safety reports (21 CFR 314.80(c)(2)) Timely submission (21 CFR 314.81(b)(2)) |
| Mar 16, 2015 | No Action Indicated (NAI) | No citations listed |
| Feb 7, 2014 | Voluntary Action Indicated (VAI) | No citations listed |
| May 15, 2012 | Voluntary Action Indicated (VAI) | Complaint Handling Procedure (21 CFR 211.198(a)) |
| Oct 29, 2010 | No Action Indicated (NAI) | No citations listed |
| May 26, 2010 | No Action Indicated (NAI) | No citations listed |
| Nov 24, 2009 | Voluntary Action Indicated (VAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Aug 17, 2013 | Class II | D-66014-001 | Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal… Failed dissolution specifications; 18 month CRT |
| Nov 30, 2009 | Class II | D-365-2010 | Ranitidine Tablets, USP, 150 mg, 500-count bottle, Rx only, Manufactured by: Amneal… Superpotent (Single Ingredient) Drug: This product is being recalled because of two reports of oversized Ranitidine Tablets. Analysis of a… |
| Aug 10, 2009 | Class II | D-1973-2009 | Naproxen Tablets, USP, 500 mg tablets, 1000 tablets per bottle, Rx only -- Manufactured… Superpotent (Single Ingredient Drug), Tablet Thickness: Amneal Pharmaceuticals has received a report of one oversized (thick) tablet of… |
| Mar 29, 2007 | Class III | D-820-2007 | Ibuprofen Tablets, USP, 200 mg (White Caplets), bulk, NET WEIGHT: 17.00 Kg, NDC… Failed USP requirement for impurity. |
FDA record score
3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
10 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Mar 18, 2019 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Apr 11, 2017 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Aug 9, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Feb 7, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-66014-001, this FEI as the recalling firm | Aug 17, 2013 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 15, 2012 | 10 years or older, so it adds no points | 0 |
| Class II recall D-365-2010, this FEI as the recalling firm | Nov 30, 2009 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Nov 24, 2009 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 18, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1973-2009, this FEI as the recalling firm | Aug 10, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 17, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 17, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 17, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 17, 2026 | Newest record Nov 16, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Amneal Pharmaceuticals Of New York, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Amneal Pharmaceuticals Of New York, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Amneal Pharmaceuticals Of New York, LLC
- Location
- Hauppauge, NY (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; LABEL; MANUFACTURE; PACK
- Source
- decrs